Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15946137rdf:typepubmed:Citationlld:pubmed
pubmed-article:15946137lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C0267952lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C0038838lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C0041242lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C0205341lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:15946137lifeskim:mentionsumls-concept:C0129975lld:lifeskim
pubmed-article:15946137pubmed:issue6lld:pubmed
pubmed-article:15946137pubmed:dateCreated2005-6-10lld:pubmed
pubmed-article:15946137pubmed:abstractTextAn oral trypsin inhibitor, camostat (CM), has a beneficial effect on chronic pancreatitis, but its mechanism is not yet fully understood. Recently, pancreatic stellate cells (PSC) have been reported to play an essential role in pancreatic fibrosis. An experimental model of pancreatic fibrosis induced by a superoxide dismutase (SOD) inhibitor (diethyldithiocarbamate [DDC]) was developed in rats. Thus, the effect of an oral trypsin inhibitor on pancreatic fibrosis and PSC was investigated.lld:pubmed
pubmed-article:15946137pubmed:languageenglld:pubmed
pubmed-article:15946137pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15946137pubmed:citationSubsetIMlld:pubmed
pubmed-article:15946137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15946137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15946137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15946137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15946137pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15946137pubmed:statusMEDLINElld:pubmed
pubmed-article:15946137pubmed:monthJunlld:pubmed
pubmed-article:15946137pubmed:issn0815-9319lld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:MizushimaTaka...lld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:TanimotoMitsu...lld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:ShinjiToshiyu...lld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:KoideNorioNlld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:MatsumuraNaok...lld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:OchiKojiKlld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:IchimuraMitsu...lld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:EmoriYasuyuki...lld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:TaniokaHiroak...lld:pubmed
pubmed-article:15946137pubmed:authorpubmed-author:ShirahigeAkin...lld:pubmed
pubmed-article:15946137pubmed:copyrightInfo(c) 2005 Blackwell Publishing Asia Pty Ltd.lld:pubmed
pubmed-article:15946137pubmed:issnTypePrintlld:pubmed
pubmed-article:15946137pubmed:volume20lld:pubmed
pubmed-article:15946137pubmed:ownerNLMlld:pubmed
pubmed-article:15946137pubmed:authorsCompleteYlld:pubmed
pubmed-article:15946137pubmed:pagination895-9lld:pubmed
pubmed-article:15946137pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:meshHeadingpubmed-meshheading:15946137...lld:pubmed
pubmed-article:15946137pubmed:year2005lld:pubmed
pubmed-article:15946137pubmed:articleTitleCamostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats.lld:pubmed
pubmed-article:15946137pubmed:affiliationDepartment of Laboratory Medicine, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.lld:pubmed
pubmed-article:15946137pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15946137pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15946137pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15946137lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15946137lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15946137lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15946137lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15946137lld:pubmed